|Bid||96.95 x 27700|
|Ask||97.60 x 21000|
|Day's range||95.80 - 97.50|
|52-week range||76.45 - 114.60|
|Beta (3Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Nov 16 (Reuters) - MorphoSys AG: * DGAP-NEWS: MORPHOSYS AND I-MAB SIGN STRATEGIC PARTNERING AGREEMENT FOR MORPHOSYS'S NOVEL IMMUNO-ONCOLOGY AGENT MOR210 * MORPHOSYS -UNDER TERMS OF AGREEMENT, I-MAB WILL ...
European shares ended a choppy session in negative territory on Tuesday as investors punished companies like Zalando that missed expectations and remained cautious while waiting for the results of U.S. ...